Back
Ligand Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
LGND
Ligand Pharmaceuticals, Inc.
Last Price:
$183.59
Seasonality Move:
3.12%
7 Day Trial
ALL ACCESS PASS
$
7
Ligand Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Ligand Pharmaceuticals, Inc. has on average historically risen by 25.2% based on the past 31 years of stock performance.
-
Ligand Pharmaceuticals, Inc. has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
-
Is Ligand Pharmaceuticals, Inc. Stock Undervalued?The current Ligand Pharmaceuticals, Inc. [LGND] share price is $183.98. The Score for LGND is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Ligand Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Ligand Pharmaceuticals, Inc. has on average historically risen by 25.2% based on the past 31 years of stock performance.
Ligand Pharmaceuticals, Inc. Stock Rating
Sell
47
Ligand Pharmaceuticals, Inc. (LGND)
is a Sell
Is Ligand Pharmaceuticals, Inc. overpriced?
-
Ligand Pharmaceuticals, Inc. has risen higher in 17 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.84%
Ligand Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ligand.com
52-Week Data
52-Week High:
212.49
52-Week Low:
93.58
Prediction Charts
Market Cap:
3.6B
Price in USD:
183.98
Volume:
163.8K
Beta:
1.45
Technical Analysis
SMA50:
193.40
SMA100:
192.33
SMA200:
162.46
52-Wk Change:
50.79%
Stock Predictions
-
Is Ligand Pharmaceuticals, Inc. stock public?Yes, Ligand Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Ligand Pharmaceuticals, Inc. stock quote today?The Ligand Pharmaceuticals, Inc. stock price is 183.98 USD today.
-
How to buy Ligand Pharmaceuticals, Inc. stock online?You can buy Ligand Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-2 | 192.18 | 197.93 | 198.18 | 191.50 |
| Feb-3 | 198.88 | 198.84 | 200.78 | 194.53 |
| Feb-4 | 200.32 | 198.33 | 201.99 | 196.07 |
| Feb-5 | 196.25 | 191.68 | 202.79 | 188.80 |
| Feb-6 | 194.61 | 190.44 | 197.00 | 189.17 |
| Feb-9 | 190.44 | 186.64 | 191.74 | 180.47 |
| Feb-10 | 186.96 | 185.97 | 187.88 | 182.65 |
| Feb-11 | 188.02 | 185.58 | 188.32 | 179.20 |
| Feb-12 | 188.21 | 181.46 | 191.47 | 180.24 |
| Feb-13 | 183.90 | 183.83 | 186.74 | 182.63 |
| Feb-17 | 184.02 | 186.97 | 189.75 | 184.02 |
| Feb-18 | 186.67 | 189.94 | 192.46 | 186.18 |
| Feb-19 | 189.54 | 186.16 | 189.54 | 183.92 |
| Feb-20 | 185.90 | 183.98 | 186.55 | 182.51 |
Ligand Pharmaceuticals, Inc. Earnings
Ligand Pharmaceuticals, Inc. Earnings Report: Per Share Ligand Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ligand Pharmaceuticals, Inc. Forecast Revenue Growth
Ligand Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Ligand Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $1.18 per share.
* Ligand Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.